DAVIGNON ETIENNE 4
4 · GILEAD SCIENCES INC · Filed May 14, 2012
Insider Transaction Report
Form 4
DAVIGNON ETIENNE
Director
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2012-05-10+8,161→ 8,161 totalExercise: $51.25Exp: 2022-05-10→ Common Stock (8,161 underlying) - Award
Restricted Stock Units
2012-05-10+2,926→ 6,558 total→ Common Stock (2,926 underlying)
Footnotes (3)
- [F1]Options vest quarterly over the first year of service and will be fully vested on May 10, 2013.
- [F2]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F3]100% of the restricted stock units will vest on May 10, 2013, at the end of the first year of service.